NASDAQ · Financial Statements

Exascale Labs Holdings Inc. (XLAB) Financial Statements

$0.97 NASDAQ: XLAB Market Cap $20.76M

Exascale Labs Holdings Inc. most recently reported annual revenue of $15.0M, net profit of $-12.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Annual Financials (USD)

Metric20252026
Revenue$7.0M$15.0M
Operating Profit$-3.0M$-5.0M
Net Profit$-8.0M$-12.0M
EPS$-5106.44$-8108.26
Op Margin-43.0%-32.0%

Balance Sheet (USD)

Metric202420252026
Total Assets—$7.0M$7.0M
Total Liabilities—$20.0M$32.0M
Cash—$4.0M$3.0M
Borrowings———

Cash Flow (USD)

Metric20252026
Operating Cash Flow$-1.0M$-3.0M
Investing Cash Flow$0$1.0M
Financing Cash Flow$4.0M$0
Net Cash Flow$3.0M$-2.0M
Free Cash Flow$-1.0M$-3.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-14.45%
Quick Ratio0.22
Interest Coverage—
Return 1Y-90.26%
Return 3Y—
Return 5Y—

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Screens featuring this stock

High ROE Technology StocksLow P/E Technology StocksHigh Net Margin Technology StocksDividend Technology StocksLow Debt Technology StocksNasdaq High ROE StocksAll stock screens
XLAB Overview XLAB Dividend Run Stock Screener